These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Multidrug-resistant tuberculosis--can the tide be turned? Zumla A; Grange JM Lancet Infect Dis; 2001 Oct; 1(3):199-202. PubMed ID: 11871496 [TBL] [Abstract][Full Text] [Related]
7. Better than a pound of cure: preventing the development of multidrug-resistant tuberculosis. Byrne AL; Fox GJ; Marais BJ Future Microbiol; 2018 Apr; 13():577-588. PubMed ID: 29521120 [TBL] [Abstract][Full Text] [Related]
8. Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatment. Hwang TJ; Keshavjee S PLoS Med; 2014 Sep; 11(9):e1001738. PubMed ID: 25268235 [TBL] [Abstract][Full Text] [Related]
9. WHO strategies for the management of drug-resistant tuberculosis. Rendon A; Centis R; D'Ambrosio L; Migliori GB Arch Bronconeumol; 2017 Mar; 53(3):95-97. PubMed ID: 27717622 [No Abstract] [Full Text] [Related]
11. Stop TB Partnership has provided treatments for 10 million people in 6 years. Wkly Epidemiol Rec; 2007 Jun; 82(22/23):206-7. PubMed ID: 17542093 [No Abstract] [Full Text] [Related]
12. [How to use rifamycin rationally: the key issue to prevent multidrug-resistant tuberculosis]. Sha W Zhonghua Jie He He Hu Xi Za Zhi; 2014 Oct; 37(10):733-6. PubMed ID: 25537407 [No Abstract] [Full Text] [Related]
13. Changing the game for multidrug-resistant tuberculosis. Ghanashyam B Lancet; 2016 Mar; 387(10024):1149-50. PubMed ID: 27025324 [No Abstract] [Full Text] [Related]
14. Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom. Williams B; Ramroop S; Shah P; Anderson L; Das S; Riddell A; Liebeschuetz S; Bernatoniene J; Shingadia D; Kampmann B Pediatr Infect Dis J; 2013 Aug; 32(8):926-7. PubMed ID: 23856715 [No Abstract] [Full Text] [Related]
16. Getting health services to three million people with TB. Pérez H J Int AIDS Soc; 2014; 17(1):19079. PubMed ID: 24666595 [No Abstract] [Full Text] [Related]
17. Drug-resistance--a challenge for tuberculosis control in the European Union and European Economic Area. van der Werf MJ; Sprenger M Euro Surveill; 2014 Mar; 19(11):. PubMed ID: 24679718 [No Abstract] [Full Text] [Related]
18. Management of contacts of multidrug-resistant tuberculosis patients in the European Union and European Economic Area. van der Werf MJ; Sandgren A; Manissero D Int J Tuberc Lung Dis; 2012; 16(3):426. PubMed ID: 22640458 [No Abstract] [Full Text] [Related]
19. Tuberculosis control goals unlikely to be met by 2005. Sharma DC Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013 [No Abstract] [Full Text] [Related]
20. Drug development for tuberculosis: the missing ingredient. Reichman LB; Fanning A Lancet; 2001 Jan; 357(9251):236. PubMed ID: 11213133 [No Abstract] [Full Text] [Related] [Next] [New Search]